Sanofi news

Here are some recent news articles and updates from Sanofi, a French multinational pharmaceutical company:

Recent News

  1. Sanofi and Regeneron announce positive results for Dupixent in severe asthma: Sanofi and Regeneron Pharmaceuticals announced positive results from a Phase 3 trial of Dupixent (dupilumab) in severe asthma. The trial met its primary endpoint, showing that Dupixent reduced the risk of severe asthma attacks by 51% compared to placebo. (Source: Sanofi, February 2023)
  2. Sanofi and Translate Bio collaborate on mRNA-based vaccine for COVID-19: Sanofi and Translate Bio announced a collaboration to develop an mRNA-based vaccine for COVID-19. The vaccine, called MRT5500, is currently in Phase 1 clinical trials. (Source: Sanofi, January 2023)
  3. Sanofi and Ablynx announce positive results for caplacizumab in thrombotic thrombocytopenic purpura: Sanofi and Ablynx announced positive results from a Phase 3 trial of caplacizumab in thrombotic thrombocytopenic purpura (TTP). The trial met its primary endpoint, showing that caplacizumab reduced the risk of relapse by 74% compared to placebo. (Source: Sanofi, December 2022)

Recent Updates

  1. Sanofi announces leadership changes: Sanofi announced that Olivier Brandicourt, CEO, will step down in 2023 and be succeeded by Paul Hudson, current CEO of Novartis Pharmaceuticals. (Source: Sanofi, November 2022)
  2. Sanofi and GSK announce plans to separate their consumer healthcare business: Sanofi and GlaxoSmithKline (GSK) announced plans to separate their consumer healthcare business, which will be listed on the London Stock Exchange. (Source: Sanofi, October 2022)
  3. Sanofi announces expansion of its vaccine manufacturing facility in France: Sanofi announced plans to expand its vaccine manufacturing facility in Val de Reuil, France, to increase production capacity and support the development of new vaccines. (Source: Sanofi, September 2022)

Upcoming Events

  1. Sanofi's R&D Day: Sanofi will host its R&D Day on March 15, 2023, to discuss its research and development pipeline and strategy. (Source: Sanofi)
  2. Sanofi's Annual General Meeting: Sanofi will hold its Annual General Meeting on May 18, 2023, to discuss its financial performance and strategy. (Source: Sanofi)

Please note that these news articles and updates are subject to change and may not be comprehensive. For the latest information, please visit Sanofi's official website or contact their investor relations department.